Oral Hypoglycemic agents Flashcards
Sulfonylureas: MOA
Increase insulin secretion
Sulfonylureas disadvantage
Hypoglycemia
Wt gain
inhibit MI
B cell exhaustion
Names of sulfonylurease
1st gen: Chlorpropamide
2nd gen: Glipizide
glyburide
name of Biguanide
Metformin
Biguanides MOA
Decrease helpatic glucose production
Biguanide advantage
Wt loss
no hypoglycemia
decrease cardiovascular risk
Biguanide disadvangages
GI upsed
B12 deficiency
CKD contradiction
Thiazolidinediones drugs
Rosiglitazone
Thiazolidinedionase MOA
Increase Peripheral insulin sensitivity
Disadvantage to Thiazolidineodinase
Wt gain
Edema, heart failure
bone fracture, LDL CVD
Advantages for thiazilidneodinase
No hypoglycemia
Beta cell preservaton
increase HDL
Glinides drugs
Repaglinide
MOA of Glinides
iincrease insuline secretion
advantage of glinides
decrease postprandial glucose
Disadvangage of glinides
B cell exhaustion
hypoglycemia
wt gain
Alpah glucosidase inhibitors MOA
Decrease intestinal carbohydrate absorption
GLIP-1 receptor agonist MOA
Increase insulin secretion
Decrease glucagon
increase satitety
GLIP-1 receptor agonist
wt loss,
injectable
Amylin mimetics moa
Activates amylin receptors
Reduce glucagon secretion
slow gastric emptying
increased satiety
Amylin Mimetics drug
pramlintide
DPP-4 inhibitors drug
sitagliptin
DPP-4 inhibitor MMA
Inhibit DPP-4
increase endogenous incretions
increase insulin secretion
Decrease glucagon
Bile acid sequestrants drug
golesevelam
bile acid sequestrants moa
Binds bile acid cholesterol
what DM drugs do not have hypoglycemia
Bile acid sequestrants
DPP-4 inhibitors
Thiazolidinediones
Biguanides
Insulin
genetic ingeneraion
Types of insuline
Regular: short acting SUBQ
Rapid Acting: Lispro, aspart
Intermediate:
Long acting
Short acting insulin
Regular: pease 50-120 min
last 508 hours
Rapid acting insulin
peak 30-90 min
Intermediate acting
Onset 1-3 horus,
Lasts 16-24 hours
Ling acting
Slow release over 18-26 hours